title: Nanotechnology inspired tools for mitochondrial dysfunction related diseases.
abstract: Mitochondrial dysfunctions are recognized as major factors for various diseases including cancer, cardiovascular diseases, diabetes, neurological disorders, and a group of diseases so called "mitochondrial dysfunction related diseases". One of the major hurdles to gain therapeutic efficiency in diseases where the targets are located in the mitochondria is the accessibility of the targets in this compartmentalized organelle that imposes barriers toward internalization of ions and molecules. Over the time, different tools and techniques were developed to improve therapeutic index for mitochondria acting drugs. Nanotechnology has unfolded as one of the logical and encouraging tools for delivery of therapeutics in controlled and targeted manner simultaneously reducing side effects from drug overdose. Tailor-made nanomedicine based therapeutics can be an excellent tool in the toolbox for diseases associated with mitochondrial dysfunctions. In this review, we present an extensive coverage of possible therapeutic targets in different compartments of mitochondria for cancer, cardiovascular, and mitochondrial dysfunction related diseases.
authors.affiliation: NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA 30602, United States.
authors.forename: Ru
authors.initials: R
authors.lastname: Wen
authors.affiliation: NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA 30602, United States.
authors.forename: Bhabatosh
authors.initials: B
authors.lastname: Banik
authors.affiliation: NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA 30602, United States.
authors.forename: Rakesh K
authors.initials: RK
authors.lastname: Pathak
authors.affiliation: NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA 30602, United States.
authors.forename: Anil
authors.initials: A
authors.lastname: Kumar
authors.affiliation: NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA 30602, United States; Partikula LLC, Sunrise, FL 33326, United States.
authors.forename: Nagesh
authors.initials: N
authors.lastname: Kolishetti
authors.affiliation: NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA 30602, United States. Electronic address: shanta@uga.edu.
authors.forename: Shanta
authors.initials: S
authors.lastname: Dhar
mesh_terms: D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D008928:Mitochondria / Q000378:metabolism*; D028361:Mitochondrial Diseases / Q000188:drug therapy / Q000378:metabolism; D036103:Nanotechnology; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D009422:Nervous System Diseases / Q000378:metabolism